BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/10/2026 6:58:03 AM | Browse: 10 | Download: 0
| Category |
Biology |
| Manuscript Type |
Minireviews |
| Article Title |
From laboratory to clinic: Bridging regulatory and manufacturing gaps in stem cell-based therapies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Noura A A Ebrahim, Thoraya A Farghaly, Ghada S Masaret, Amani M R Alsaedi and Soliman M A Soliman |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Noura A A Ebrahim, Department of Oncologic Pathology, National Cancer Institute, Cairo University, 1st Kasr Al Ainy Street, Cairo 11796, Al Qāhirah, Egypt. npathologist@gmail.com |
| Key Words |
Advanced therapy medicinal products; Stem cell manufacturing platforms; Global regulatory alignment; Safety and tumorigenicity of induced pluripotent stem cells-derived products; Exosome-based mesenchymal stem cell therapies |
| Core Tip |
This review outlines the major scientific, regulatory, and manufacturing challenges that limit the clinical translation of stem cell-based advanced therapies. It highlights practical strategies - ranging from tumorigenicity assessment for induced pluripotent stem cells and good manufacturing practice-ready production of mesenchymal stem cell-derived exosomes to artificial intelligence-driven process monitoring and digital-twin modeling - that can support safer, scalable, and more consistent development of stem cell and extracellular-vesicle therapeutics. |
| Citation |
Ebrahim NAA, Farghaly TA, Masaret GS, Alsaedi AMR, Soliman SMA. From laboratory to clinic: Bridging regulatory and manufacturing gaps in stem cell-based therapies. World J Stem Cells 2026; In press |
 |
Received |
|
2025-12-11 01:13 |
 |
Peer-Review Started |
|
2025-12-11 01:13 |
 |
First Decision by Editorial Office Director |
|
2026-01-22 07:58 |
 |
Return for Revision |
|
2026-01-22 07:58 |
 |
Revised |
|
2026-02-05 00:33 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-03-05 02:56 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-10 06:58 |
 |
Articles in Press |
|
2026-03-10 06:58 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345